Biodexa Pharmaceuticals (BDRX) Times Interest Earned (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) has 12 years of Times Interest Earned data on file, last reported at -$14.87 in Q2 2025.

• For the quarter ending Q2 2025, Times Interest Earned changed N/A year-over-year to -$14.87; the trailing twelve-month figure through Jun 2025 stood at -$85.36 (changed N/A YoY), and the FY2025 full-year result was -$37.75, up 32.29% from the prior year.
• Times Interest Earned slipped to -$14.87 in Q2 2025, from $86.18 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $192.91 in Q2 2023 to a low of -$14.87 in Q2 2025.
• A 5-year average of $88.64 and a median of $86.18 in 2024 frame the typical range for Times Interest Earned.
• Across the five-year window, Times Interest Earned tumbled 61.22% in 2021 and surged 659.34% in 2022, its largest moves.
• Tracing BDRX's Times Interest Earned over 5 years: stood at $20.73 in 2021, then jumped by 659.34% to $157.42 in 2022, then advanced by 22.55% to $192.91 in 2023, then tumbled by 55.32% to $86.18 in 2024, then slumped by 117.26% to -$14.87 in 2025.
• Business Quant data shows BDRX's Times Interest Earned at -$14.87 in Q2 2025, $86.18 in Q4 2024, and $192.91 in Q2 2023.